000 | 01841cam a2200277zu 4500 | ||
---|---|---|---|
001 | 88835309 | ||
003 | FRCYB88835309 | ||
005 | 20250107104134.0 | ||
006 | m o d | ||
007 | cr un | ||
008 | 250107s2016 fr | o|||||0|0|||eng d | ||
020 | _a9780128028261 | ||
035 | _aFRCYB88835309 | ||
040 |
_aFR-PaCSA _ben _c _erda |
||
100 | 1 | _aPeiman, Hematti | |
245 | 0 | 1 |
_aMesenchymal Stromal Cells _bTranslational Pathways to Clinical Adoption _c['Peiman, Hematti'] |
264 | 1 |
_bElsevier Science _c2016 |
|
300 | _a p. | ||
336 |
_btxt _2rdacontent |
||
337 |
_bc _2rdamdedia |
||
338 |
_bc _2rdacarrier |
||
650 | 0 | _a | |
700 | 0 | _aPeiman, Hematti | |
856 | 4 | 0 |
_2Cyberlibris _uhttps://international.scholarvox.com/netsen/book/88835309 _qtext/html _a |
520 | _aMesenchymal Stromal Cells: Translational Pathways to Clinical Adoption provides the latest information on the necessary steps for successful production of stem cells for a clinical trial. Written by professionals with hands-on experience in bringing MSC therapies to the clinic, and building on the biology and mechanisms of action, this unique book covers the development and production of clinical-grade products that are suitable for use in humans. From design of a cell production facility, to obtaining regulatory approval and reimbursement issues, it is a useful guide for researchers and administrators across biomedical research.Provides methodologies for clinical MSC production, from designing a facility, to post-market approvalIncludes real-life examples of MSC production in academic centers and MSC production for biopharmaceutical clinical trialsOffers a unique perspective on the clinical aspects of MSC studies Presents the principles of clinical trials that can be applied to the production of various cell therapies | ||
999 |
_c14814 _d14814 |